Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Clinical trial NCT03999515 · TERMINATED

Trial details

NCT number: NCT03999515
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Double-Negative Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Adenocarcinoma Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2020-04-27
Primary completion: 2021-06-06
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.